Cargando…
Crohn-like disease long remission in a pediatric patient with glycogen storage disease type Ib treated with empagliflozin: a case report
Glycogen storage disease type Ib (GSD Ib) is a rare hereditary glycogen disorder that results in inadequate maintenance of glucose homeostasis, accumulation of glycogen in different organs, loss and dysfunction of neutrophils. Crohn’s-like disease is observed in up to 24–77% of GDS Ib cases. Recentl...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540602/ https://www.ncbi.nlm.nih.gov/pubmed/37779861 http://dx.doi.org/10.1177/17562848231202138 |
_version_ | 1785113745720082432 |
---|---|
author | Calia, Margherita Arosio, Andrea Mario Luciano Crescitelli, Viola Fornari, Anna Pretese, Roberta Gasperini, Serena Zuin, Giovanna |
author_facet | Calia, Margherita Arosio, Andrea Mario Luciano Crescitelli, Viola Fornari, Anna Pretese, Roberta Gasperini, Serena Zuin, Giovanna |
author_sort | Calia, Margherita |
collection | PubMed |
description | Glycogen storage disease type Ib (GSD Ib) is a rare hereditary glycogen disorder that results in inadequate maintenance of glucose homeostasis, accumulation of glycogen in different organs, loss and dysfunction of neutrophils. Crohn’s-like disease is observed in up to 24–77% of GDS Ib cases. Recently, empagliflozin has been recommended as a treatment for neutrophil dysfunction in GDS Ib patients with or without Crohn’s-like disease. There are no guidelines for the treatment of inflammatory bowel disease (IBD) manifestation in GSD Ib patients, although some cases have been treated with granulocyte colony-stimulating factor and others with IBD conventional therapy, resulting in partial IBD remission. Herein, we describe a child with GDS Ib and Crohn’s-like disease who was treated with empagliflozin and achieved complete remission after 2 years of treatment. This case is the first one with such a long follow-up evaluation including endoscopic and magnetic resonance enterography assessment. Our clinical evidence of remission of IBD manifestation in our GSD Ib patient and the role of neutrophils in GDS Ib described in the literature suggest a strong association with IBD pathophysiology and neutrophil function. The use of empagliflozin resulted in significant improvements in gastrointestinal symptoms, reduced drug usage, and enhanced quality of life in the patient, with a favorable safety profile, offering a promising new therapeutic option for this population. |
format | Online Article Text |
id | pubmed-10540602 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-105406022023-09-30 Crohn-like disease long remission in a pediatric patient with glycogen storage disease type Ib treated with empagliflozin: a case report Calia, Margherita Arosio, Andrea Mario Luciano Crescitelli, Viola Fornari, Anna Pretese, Roberta Gasperini, Serena Zuin, Giovanna Therap Adv Gastroenterol Case Report Glycogen storage disease type Ib (GSD Ib) is a rare hereditary glycogen disorder that results in inadequate maintenance of glucose homeostasis, accumulation of glycogen in different organs, loss and dysfunction of neutrophils. Crohn’s-like disease is observed in up to 24–77% of GDS Ib cases. Recently, empagliflozin has been recommended as a treatment for neutrophil dysfunction in GDS Ib patients with or without Crohn’s-like disease. There are no guidelines for the treatment of inflammatory bowel disease (IBD) manifestation in GSD Ib patients, although some cases have been treated with granulocyte colony-stimulating factor and others with IBD conventional therapy, resulting in partial IBD remission. Herein, we describe a child with GDS Ib and Crohn’s-like disease who was treated with empagliflozin and achieved complete remission after 2 years of treatment. This case is the first one with such a long follow-up evaluation including endoscopic and magnetic resonance enterography assessment. Our clinical evidence of remission of IBD manifestation in our GSD Ib patient and the role of neutrophils in GDS Ib described in the literature suggest a strong association with IBD pathophysiology and neutrophil function. The use of empagliflozin resulted in significant improvements in gastrointestinal symptoms, reduced drug usage, and enhanced quality of life in the patient, with a favorable safety profile, offering a promising new therapeutic option for this population. SAGE Publications 2023-09-28 /pmc/articles/PMC10540602/ /pubmed/37779861 http://dx.doi.org/10.1177/17562848231202138 Text en © The Author(s), 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Case Report Calia, Margherita Arosio, Andrea Mario Luciano Crescitelli, Viola Fornari, Anna Pretese, Roberta Gasperini, Serena Zuin, Giovanna Crohn-like disease long remission in a pediatric patient with glycogen storage disease type Ib treated with empagliflozin: a case report |
title | Crohn-like disease long remission in a pediatric patient with glycogen storage disease type Ib treated with empagliflozin: a case report |
title_full | Crohn-like disease long remission in a pediatric patient with glycogen storage disease type Ib treated with empagliflozin: a case report |
title_fullStr | Crohn-like disease long remission in a pediatric patient with glycogen storage disease type Ib treated with empagliflozin: a case report |
title_full_unstemmed | Crohn-like disease long remission in a pediatric patient with glycogen storage disease type Ib treated with empagliflozin: a case report |
title_short | Crohn-like disease long remission in a pediatric patient with glycogen storage disease type Ib treated with empagliflozin: a case report |
title_sort | crohn-like disease long remission in a pediatric patient with glycogen storage disease type ib treated with empagliflozin: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10540602/ https://www.ncbi.nlm.nih.gov/pubmed/37779861 http://dx.doi.org/10.1177/17562848231202138 |
work_keys_str_mv | AT caliamargherita crohnlikediseaselongremissioninapediatricpatientwithglycogenstoragediseasetypeibtreatedwithempagliflozinacasereport AT arosioandreamarioluciano crohnlikediseaselongremissioninapediatricpatientwithglycogenstoragediseasetypeibtreatedwithempagliflozinacasereport AT crescitelliviola crohnlikediseaselongremissioninapediatricpatientwithglycogenstoragediseasetypeibtreatedwithempagliflozinacasereport AT fornarianna crohnlikediseaselongremissioninapediatricpatientwithglycogenstoragediseasetypeibtreatedwithempagliflozinacasereport AT preteseroberta crohnlikediseaselongremissioninapediatricpatientwithglycogenstoragediseasetypeibtreatedwithempagliflozinacasereport AT gasperiniserena crohnlikediseaselongremissioninapediatricpatientwithglycogenstoragediseasetypeibtreatedwithempagliflozinacasereport AT zuingiovanna crohnlikediseaselongremissioninapediatricpatientwithglycogenstoragediseasetypeibtreatedwithempagliflozinacasereport |